Ion Beam Applications SA (IOBCF)

Market Cap	517.13M +35.9%
Revenue (ttm)	730.04M +7.1%
Net Income	28.12M +44.7%
EPS	0.91 +38.9%
Shares Out	n/a
PE Ratio	18.39
Forward PE	19.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	17.80
Previous Close	17.50
Day's Range	17.70 - 18.50
52-Week Range	11.45 - 20.10
Beta	1.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Ion Beam Applications

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates through four segments, Clinical Proton Therapy; Clinical Dosimetry; IBA Technologies; and IBA Corporate. The company develops ConformalFLASH, a novel technique using the proton Bragg peak; DynamicARC, a technique that allows dynamic spot scanning irradiation and energy switching while the gantry is rotating; Proteus ONE, a compa...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 2,264
• Stock Exchange: OTCMKTS
• Ticker Symbol: IOBCF

Financial Performance

In 2025, Ion Beam Applications's revenue was 620.18 million, an increase of 24.49% compared to the previous year's 498.16 million. Earnings were 12.73 million, an increase of 37.59%.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error